From: A novel protein purification scheme based on salt inducible self-assembling peptides
Type | Target protein | Intein | 0.7Â M Na2SO4 | 3Â M NaCl | 0.7Â M (NH4)2SO4 | Specific activity of purified proteins and peptides | Specific activity of commercial or literature-sourced proteins and peptides | |||
---|---|---|---|---|---|---|---|---|---|---|
Yielda (mg/L) | Purityb (%) | Yielda (mg/L) | Purityb (%) | Yielda (mg/L) | Purityb (%) | |||||
Therapeutic protein | hGH | Mtu ΔI-CM | 87 ± 6 | 97 ± 1 | 81 ± 12 | 94 ± 7 | 127 ± 16 | 88 ± 7 | 0.13–0.19 nMc | 0.15 nMd |
Peptide | LCB3 | Mtu ΔI-CM | 12 ± 3 | 72 ± 1 | 10 ± 6 | 71 ± 16 | 4 ± 3 | 33 ± 8 | 0.31–0.43 nMc | < 1 nM [32] |
Multivalent scaffold protein | SpyCatcherΔN-ELP-SpyCatcherΔN | Mtu ΔI-CM | 40 ± 9 | 96 ± 1 | 45 ± 8 | 98 ± 1 | 40 ± 6 | 85 ± 4 | ~ 99%e | ~ 80%f [34] |
Industrial enzyme | xylanase | Mtu ΔI-CM | 32 ± 4 | 79 ± 1 | 24 ± 4 | 67 ± 3 | 18 ± 1 | 59 ± 4 | 12.37–26.19 units/mg | ≥ 2.50 units/mgg |
Mxe GyrA | 84 ± 6 | 87 ± 6 | 35 ± 13 | 49 ± 15 | 37 ± 6 | 54 ± 7 | 13.31–28.60 units/mg |